Nasdaq: RTSN · Listed Oct 9, 2026
Retension Pharmaceuticals IPO
$13.89
▲ +21.73%today · +15.75% since the $12.00 IPO price
15-minute delayed · as of 7:30:03 PM EST on Nov 18, 2026
Retension Pharmaceuticals (RTSN) priced its IPO at $12.00 a share and has traded on Nasdaq since Oct 9, 2026.
Last session · Nov 18, 2026
- Market cap
- $115.73M
- from the ticker reference
- Volume
- 104.06K
- shares, regular session
- VWAP
- $12.90
- the last price is +7.67% from the volume-weighted average
- Day range
- 11.45–14.16
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
RTSN against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
RTSN against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals '26 | $45M | -16.67% | -8.17% | +3.33% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Retension Pharmaceuticals IPO offers 3.75M shares to raise $45M, before any underwriters' option.
- Expected price range
- $11 to $13
- IPO price
- $12.00
- Shares offered
- 3.75M
- Money raised
- $45M
- Listing date
- Oct 9, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Retension Pharmaceuticals$45M
Where RTSN ranks
Retension Pharmaceuticals's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- RTSN$115.73M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 9, 2026
First trade
Prices, bars, and snapshots
Oct 14, 2026 · est.
Options list
Option chain and open interest
Oct 29, 2026 · est.
First short interest
Short interest and daily short volume
Nov 3, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 6, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What Retension Pharmaceuticals has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Retension Pharmaceuticals discloses to the SEC on Form 8-K.
- Quarterly earningsNov 18, 2026
On November 18, 2026, Retension Pharmaceuticals, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026.
- Executive compensation changeOct 23, 2026
The Company and Mr. Wong entered into an Offer Letter establishing the terms of Mr. Wong's employment with the Company, which provides for an annual base salary of $360,000, eligibility for a discretionary bonus with a target opportunity equal to 30% of his base salary, and a sign-on bonus of $20,000.
- Charter amendmentOct 13, 2026
In connection with the closing of the Company's initial public offering (the "IPO") on October 13, 2026, the Company filed its Third Amended and Restated Certificate of Incorporation (the "Amended and Restated Certificate") with the Secretary of State of the State of Delaware on October 9, 2026. The Company's board of directors (the "Board") and stockholders previously approved the Amended and Restated Certificate to be filed in connection with, and become effective immediately prior to, the closing of the IPO.
About Retension Pharmaceuticals
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.
- Ticker
- RTSN
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- PHARMACEUTICAL PREPARATIONS
- Listed
- Oct 9, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Retension Pharmaceuticals IPO price?
$12.00 a share.
When did Retension Pharmaceuticals go public?
Retension Pharmaceuticals listed on Nasdaq on Oct 9, 2026 under the ticker RTSN.
How much did the Retension Pharmaceuticals IPO raise?
$45M, before any underwriters' option.
How did Retension Pharmaceuticals open on its first day?
RTSN first traded at $10.00, -16.67% from the IPO price of $12.00.
How did RTSN close on its first day?
Its last regular-session trade was $11.02, -8.17% from the IPO price of $12.00.
What was the RTSN first-day trading range?
$9.66 to $11.60 in the regular session.
How many RTSN shares traded on the first day?
723.79K shares in the regular session.
How many shares did Retension Pharmaceuticals sell in its IPO?
3.75M shares.
What exchange is RTSN listed on?
Retension Pharmaceuticals lists on Nasdaq under the ticker RTSN.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the RTSN data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/RTSN/range/5/minute |
| Market cap | /v3/reference/tickers/RTSN |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.